Literature DB >> 17997397

Analysis of NR3A receptor subunits in human native NMDA receptors.

Anna Nilsson1, Maria Eriksson, E Chris Muly, Elisabet Akesson, Eva-Britt Samuelsson, Nenad Bogdanovic, Eirikur Benedikz, Erik Sundström.   

Abstract

NR3A, representing the third class of NMDA receptor subunits, was first studied in rats, demonstrating ubiquitous expression in the developing central nervous system (CNS), but in the adult mainly expressed in spinal cord and some forebrain nuclei. Subsequent studies showed that rodent and non-human primate NR3A expression differs. We have studied the distribution of NR3A in the human CNS and show a widespread distribution of NR3A protein in adult human brain. NR3A mRNA and protein were found in all regions of the cerebral cortex, and also in the subcortical forebrain, midbrain and hindbrain. Only very low levels of NR3A mRNA and protein could be detected in homogenized adult human spinal cord, and in situ hybridization showed that expression was limited to ventral motoneurons. We found that NR3A is associated with NR1, NR2A and NR2B in adult human CNS, suggesting the existence of native NR1-NR2A/B-NR3A assemblies in adult human CNS. While NR1 and NR2A could only be efficiently solubilized by deoxycholate, NR3A was extracted by all detergents, suggesting that a large fraction is weakly anchored to cell membranes and other proteins. Using size exclusion chromatography we found that just as for NR1, a large fraction of NR3A exists as monomers and dimers, suggesting that these two glycine binding subunits behave similarly with regard to receptor assembly and trafficking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997397     DOI: 10.1016/j.brainres.2007.09.008

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

Review 2.  Shuffling the deck anew: how NR3 tweaks NMDA receptor function.

Authors:  Nora A Cavara; Michael Hollmann
Journal:  Mol Neurobiol       Date:  2008-07-25       Impact factor: 5.590

Review 3.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

Review 4.  Emerging roles of GluN3-containing NMDA receptors in the CNS.

Authors:  Isabel Pérez-Otaño; Rylan S Larsen; John F Wesseling
Journal:  Nat Rev Neurosci       Date:  2016-08-25       Impact factor: 34.870

5.  Neuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cells.

Authors:  Jun-Qiang Yan; Yu-Jin Ma; Jia-Chun Sun; Shu-Feng Bai; Li-Na Huang
Journal:  Int J Clin Exp Med       Date:  2014-10-15

6.  Significant association of glutamate receptor, ionotropic N-methyl-D-aspartate 3A (GRIN3A), with nicotine dependence in European- and African-American smokers.

Authors:  Jennie Z Ma; Thomas J Payne; Justin Nussbaum; Ming D Li
Journal:  Hum Genet       Date:  2010-01-19       Impact factor: 4.132

Review 7.  Influence of the NR3A subunit on NMDA receptor functions.

Authors:  Maile A Henson; Adam C Roberts; Isabel Pérez-Otaño; Benjamin D Philpot
Journal:  Prog Neurobiol       Date:  2010-01-25       Impact factor: 11.685

8.  NMDA Receptors in the Central Nervous System.

Authors:  Kasper B Hansen; Feng Yi; Riley E Perszyk; Frank S Menniti; Stephen F Traynelis
Journal:  Methods Mol Biol       Date:  2017

9.  Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.

Authors:  Junqiang Yan; Yunqi Xu; Cansheng Zhu; Limin Zhang; Aimin Wu; Yu Yang; Zhaojun Xiong; Chao Deng; Xu-Feng Huang; Midori A Yenari; Yuan-Guo Yang; Weihai Ying; Qing Wang
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

10.  Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.

Authors:  Weiwei Zhong; Anika Wu; Ken Berglund; Xiaohuan Gu; Michael Qize Jiang; Jay Talati; Jingjie Zhao; Ling Wei; Shan Ping Yu
Journal:  Alzheimers Dement       Date:  2021-06-20       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.